Please check your internet connection and try again.
# Walethmade Bromide
## Overview
Walethmade bromide is a medication whose specific formulation and approved indications are not readily identifiable in standard drug compendia. This response is based on the general class of bromide salts, which have historically been used as sedatives and anticonvulsants.
## Primary Indications
Historically, bromide salts have been used for:
* Epilepsy (adjunctive therapy)
* Nervousness and agitation
**Note:** Due to a narrow therapeutic index, potential for toxicity, and the availability of safer and more effective agents, bromide salts are rarely used today.
## Adult Dosing
There is no current standard dosing for Walethmade bromide. Historically, dosages varied significantly. For example, sodium bromide was sometimes initiated at 0.5 to 1 gram orally three times daily, with a maximum of 4 grams daily, but this is not a recommendation.
## Pediatric Dosing
There is no established pediatric dosing for Walethmade bromide.
## Dose Adjustments
Dose adjustments would be critical due to the narrow therapeutic index and potential for accumulation. Specific adjustments are not possible without established dosing guidelines.
## Contraindications
* Hypersensitivity to bromide
* Severe renal impairment (due to risk of accumulation)
## Adverse Effects
Common adverse effects are related to bromism, which can manifest as:
* Neurological: Lethargy, somnolence, confusion, memory impairment, psychosis, ataxia, tremor, headache.
* Gastrointestinal: Nausea, vomiting, anorexia, constipation.
* Dermatological: Acneiform rash, purpura.
## Key Drug Interactions
* **CNS Depressants (alcohol, benzodiazepines, opioids):** Additive sedative effects.
* **Diuretics (especially thiazides and loop diuretics):** May enhance bromide excretion, potentially leading to withdrawal symptoms if stopped abruptly. Conversely, some diuretics may potentially increase bromide reabsorption.
## Monitoring
* **Therapeutic Drug Monitoring:** Serum bromide levels are essential to guide dosing and prevent toxicity. Target levels are generally considered to be between 25 and 50 mg/dL, though this can vary.
* **Renal Function:** Monitor creatinine and BUN regularly, especially in patients with renal impairment or risk factors.
* **Neurological and Psychiatric Status:** Closely monitor for signs and symptoms of bromism.
## Clinical Pearls
* Bromism can develop insidiously and is often misdiagnosed as a psychiatric disorder or worsening of the underlying condition.
* Treatment is primarily supportive and involves discontinuing the bromide salt and promoting excretion, often with saline diuresis.
* Due to significant safety concerns and availability of superior alternatives, bromide salts are generally not recommended for use.
---
**Disclaimer:** This information is for educational purposes only and does not constitute medical advice. It is essential to consult the most current prescribing information and guidelines for Walethmade bromide, as well as individual patient factors, prior to making any clinical decisions. Information on this specific product may be limited or outdated.
